Cyclical Treatment of Colorectal Tumor Spheroids Induces Resistance to MEK Inhibitors
Adaptive drug resistance is a major obstacle to successful treatment of colorectal cancers. Physiologic tumor models of drug resistance are crucial to understand mechanisms of treatment failure and improve therapy by developing new therapeutics and treatment strategies. Using our aqueous two-phase s...
Main Authors: | Pradip Shahi Thakuri, Gary D. Luker, Hossein Tavana |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-03-01
|
Series: | Translational Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523318305862 |
Similar Items
-
Phytochemicals inhibit migration of triple negative breast cancer cells by targeting kinase signaling
by: Pradip Shahi Thakuri, et al.
Published: (2020-01-01) -
MEK inhibitors activate Wnt signalling and induce stem cell plasticity in colorectal cancer
by: Tianzuo Zhan, et al.
Published: (2019-05-01) -
Concurrent MEK2 Mutation and BRAF Amplification Confer Resistance to BRAF and MEK Inhibitors in Melanoma
by: Jessie Villanueva, et al.
Published: (2013-09-01) -
Concurrent inhibition of FAK/SRC and MEK overcomes MEK inhibitor resistance in Neurofibromatosis Type I related malignant peripheral nerve sheath tumors
by: Yihui Gu, et al.
Published: (2022-07-01) -
Implication of Intra-Tumor Heterogeneity on Colorectal Cancer Response to MEK Inhibition
by: Christian Regenbrecht
Published: (2023-03-01)